How to Diagnose Strep Throat: Rapid Tests vs. Cultures

Strep throat is diagnosed through laboratory testing, not symptoms alone. The two most common methods are rapid antigen detection tests, which return results in minutes, and throat cultures, which take one to two days but catch more infections. A third option, molecular testing using DNA amplification, is gaining ground as a fast and highly accurate alternative. Which test you get depends on your age, where you seek care, and what guidelines your clinician follows.

Why Symptoms Alone Are Not Enough

Strep throat and viral sore throats can look identical. Fever, swollen tonsils, and tender neck lymph nodes all overlap between the two. Clinicians have tried for decades to use bedside scoring systems to sort strep from non-strep. The most widely used are the Centor score and its modified version, the McIsaac score, which assign points for clinical features like tonsillar exudates, fever, absence of cough, and swollen anterior cervical nodes (with the McIsaac version adjusting for age).

These scores are useful for deciding who should be tested, but they are not accurate enough to diagnose strep on their own. A large validation study found that both scores had an area under the curve of only about 0.71 to 0.72, meaning they perform modestly better than a coin flip at distinguishing strep from other causes of sore throat.¹ A meta-analysis of these scoring systems in secondary care found that at the thresholds guidelines recommend, the Centor score at a cutoff of 3 catches fewer than half of true strep cases, while the McIsaac score at a threshold of 2 or 3 catches more cases but at the cost of flagging many people who do not actually have strep.²

In practice, this means the scores help clinicians decide whom to test rather than whom to treat. A patient with a very low score probably does not need a strep test at all, while a patient with a moderate or high score should get laboratory confirmation before antibiotics are prescribed.

Rapid Antigen Detection Tests

Rapid antigen detection tests, often called “rapid strep tests,” are the frontline tool in most clinics. A healthcare provider swabs the back of your throat and tonsils, then runs the swab through a test that detects proteins on the surface of group A Streptococcus bacteria. Results typically come back within five to ten minutes.

The biggest strength of rapid tests is their specificity: when they say you have strep, they are almost always right. False positives are rare. The weakness is sensitivity. A Cochrane review of rapid antigen tests in children found that both major types of immunoassay-based tests had a sensitivity of roughly 85 to 86%, meaning they miss about one in seven true infections.³ That miss rate is not trivial when the stakes include complications like rheumatic fever.

Real-world performance varies more than those summary numbers suggest. Test sensitivity depends on the amount of bacteria present in the throat, the skill of the person performing the swab, and even the specific brand of test kit used. A systematic review noted high variability in sensitivity tied to clinical spectrum, the size of the bacterial load on the swab, technical training, and who was doing the testing.⁴ In one head-to-head study, a particular rapid test kit detected only about 5% of culture-positive specimens, an extreme outlier that underscores how much brand and technique matter.⁵

Because of this miss rate, guidelines in many countries recommend that a negative rapid test in a child be followed up with a throat culture. The American Academy of Pediatrics has long recommended backing up negative rapid tests with culture in children.⁶ The reasoning is simple: children face a higher risk of rheumatic fever, and missing a case is more consequential. For adults, European guidelines have taken a different stance, suggesting that a negative rapid test is sufficient and culture backup is not necessary.⁷ Adults are less likely to develop rheumatic fever and less likely to have strep in the first place.

Throat Culture as the Traditional Gold Standard

Throat culture has been the reference standard for strep diagnosis for decades. A swab from the throat is streaked onto a blood agar plate and incubated, typically for 18 to 48 hours, to see whether group A Streptococcus grows.⁸ The bacteria produce a characteristic pattern of hemolysis, the clear zones around colonies where red blood cells in the agar have been destroyed, which allows lab technicians to identify them.

Culture’s advantage is sensitivity. It catches infections that rapid tests miss, especially those with lower bacterial loads. One study evaluating a specific rapid test brand found that it detected a very high proportion of culture-positive cases with a sensitivity above 96% and perfect specificity, showing that some newer rapid tests are closing the gap with culture, though performance still varies by brand.⁹ The culture method also allows identification of other bacterial species beyond group A strep, which rapid antigen tests cannot do.

The main disadvantage is turnaround time. A one-to-two-day wait means clinicians must either delay treatment or make a judgment call about starting antibiotics before results come back. Selective media, such as blood agar plates containing trimethoprim-sulfamethoxazole to suppress normal throat flora, and careful incubation conditions improve recovery rates.¹⁰ But even with optimized methods, culture is not infallible. Technique, transport conditions, and laboratory handling all affect whether bacteria survive long enough to grow.

How the Swab Is Taken and Handled

Both rapid tests and cultures are only as good as the sample collected. The swab needs to firmly contact the posterior pharynx and both tonsils, ideally collecting visible exudate if present. A timid swab that barely grazes the back of the throat can easily produce a false negative. Research has noted that most false-negative rapid test results trace back to faulty technique or poor preservation of the test kit.¹¹

For cultures, how quickly the swab gets plated matters. One study found a significant drop in sensitivity when swabs were stored overnight rather than processed within four hours, particularly for samples with heavier bacterial loads.¹² Counterintuitively, a separate older study found that a brief delay in plating, when swabs were stored at room temperature for a few days, actually increased isolation rates of group A strep compared to immediate plating, possibly because the bacteria had time to multiply on the swab while competing normal flora died off.¹³ These contradictory findings reflect the complexity of specimen handling: the optimal approach depends on the swab type, transport medium, and storage conditions.

In remote settings where samples must travel to a distant lab, studies have compared different transport methods. Research in remote tropical communities found that direct plating onto culture media with cold-box transport was superior to transporting dry swabs, but that including a silica gel desiccant in the transport tube and keeping samples cool brought recovery rates close to those of immediate plating.¹⁴ For most readers visiting a clinic in a developed country, sample handling is handled for you. But if you are using an at-home test kit or being swabbed at a pharmacy, the same principles apply: a thorough swab, processed promptly, gives the most trustworthy result.

Molecular Tests and the Shift Toward PCR

The newest category of strep test uses nucleic acid amplification, essentially looking for strep DNA rather than strep proteins or live bacteria. These molecular tests combine the speed of a rapid test (results in about 15 to 30 minutes for point-of-care versions) with sensitivity and specificity that rival or exceed culture.

In a study comparing three molecular platforms against both culture and a rapid antigen test, all three nucleic acid tests achieved sensitivities and specificities above 95%. Two of the platforms hit 100% sensitivity and about 97% specificity. The rapid antigen kit tested alongside them, by contrast, performed poorly in that particular comparison.⁵ Molecular point-of-care tests can simplify the diagnostic workflow by eliminating the need for a backup culture after a negative result, since the test itself is sensitive enough to stand alone.¹⁵

One cost-effectiveness analysis found that a point-of-care molecular testing strategy would cost roughly $44 per patient, compared with $78 for the traditional rapid-test-plus-backup-culture approach. The molecular test itself costs more, but by getting the right answer the first time, it reduces the downstream expenses of misdiagnosis: unnecessary antibiotics, untreated complications, and return visits.¹⁶ These tests are not yet available everywhere, and many clinics still rely on rapid antigen tests as the first step. But their adoption is growing, especially in pediatric settings where the consequences of a missed diagnosis are highest.

The Carrier Problem

One complication that no test fully resolves is the strep carrier state. Some people, children especially, carry group A Streptococcus in their throats without being sick. When a carrier gets a viral sore throat, a strep test will come back positive, but the strep is not the cause of their symptoms. The result: antibiotics for a virus, with no benefit and potential side effects.

This carrier state has been recognized and studied for decades, yet it remains poorly understood in terms of exactly who becomes a carrier, how long the state lasts, and when or whether treatment is justified.¹⁷ A meta-analysis estimated that among children under 20, roughly a quarter of sore-throat visits are culture-positive for group A strep.¹⁸ But some fraction of those positive results are carriers with a coincidental viral infection rather than true strep pharyngitis. No currently available test can distinguish a true infection from carriage; that distinction still depends on the clinician’s judgment, informed by the clinical picture and the patient’s history.

Molecular tests may actually make the carrier problem slightly worse. Because they are more sensitive, they pick up smaller quantities of bacteria, including amounts that may reflect carriage rather than active infection. A culture might not grow enough colonies to call positive, while a PCR test could detect the DNA from the same small population. This is a trade-off with no easy answer: higher sensitivity catches more true infections but also flags more carriers.

When It Is Not Group A Strep

Standard rapid antigen tests are designed to detect only group A Streptococcus. They will not flag group C or group G streptococci, which can cause identical-looking pharyngitis. Group C strep is a recognized cause of severe sore throat, particularly among college students and young adults presenting to emergency departments. Its clinical presentation, including exudative pharyngitis, is indistinguishable from group A disease.¹⁹ Group G strep can present similarly, though it is less common.

A systematic review and meta-analysis found that group C strep does not appear to be associated with sore throats in children any more than in healthy controls, but in adults, it was found in about 11% of sore throat patients compared to roughly 6% of controls, suggesting a real, if weaker, association with illness.²⁰ If you are a young adult with a convincing strep picture and a negative rapid test, group C or G strep is worth considering. Culture can detect these organisms, which is one reason clinicians sometimes order a culture even when they are not specifically worried about a false-negative rapid test for group A.

How Testing Shapes Antibiotic Prescribing

One of the biggest practical benefits of strep testing is not just finding out whether you have strep. It is keeping people who do not have strep off antibiotics they do not need. Most sore throats are viral, and antibiotics do nothing for them except cause side effects and contribute to antibiotic resistance.

A Cochrane review found that using rapid tests to guide prescribing decisions led to roughly a 25 percentage-point reduction in antibiotic prescriptions compared to managing sore throats based on clinical judgment alone.²¹ A randomized trial of adults with acute pharyngitis found that clinicians without access to rapid tests prescribed antibiotics about 64% of the time, while those who used rapid tests prescribed them about 44% of the time. Inappropriate prescribing, defined as giving antibiotics when they were not indicated, was about 60% in the no-test group and roughly 27% in the rapid-test group.²²

A survey of over 1,200 medical practices in Germany reinforced this pattern: physicians who used point-of-care testing for sore throats reported high satisfaction and believed it substantially reduced unnecessary antibiotic use.²³ The implication is clear: without a test, clinicians prescribe antibiotics for sore throats far more often than the actual rate of strep warrants. The test changes the conversation from “let’s treat just in case” to “let’s confirm and then decide.”

Why Strep Diagnosis Still Matters

It is fair to wonder why strep throat gets so much diagnostic attention when it usually resolves on its own. The answer is rheumatic fever, an inflammatory condition that can damage the heart. Rheumatic fever has become rare in wealthy countries precisely because clinicians identify and treat strep pharyngitis with antibiotics. Proper identification and adequate antibiotic treatment of group A streptococcal pharyngitis remains the primary strategy for preventing rheumatic fever.²⁴ In parts of the world where access to testing and treatment is limited, rheumatic heart disease remains a major cause of illness and death. The diagnostic infrastructure around strep throat exists largely because the downstream consequences of missing it can be severe and permanent.

Cost Differences Across Testing Strategies

The economics of strep testing are more complex than the sticker price of a single test. An older cost-effectiveness analysis for children found that culture alone was actually the least expensive strategy at about $7 per patient under baseline assumptions, beating out rapid-test-only and combined strategies in both cost and effectiveness.²⁵ But that analysis assumed patients could wait for culture results, which is often impractical. A separate decision analysis that factored in complication costs found that the combined strategy of rapid test followed by backup culture was the most cost-effective approach overall, because it caught infections quickly while still catching the ones the rapid test missed.²⁶

Molecular point-of-care tests shift this calculation again. Though the per-test cost is higher, modeling suggests they reduce total costs per patient compared to the rapid-test-plus-culture workflow by eliminating the backup culture step and reducing misdiagnosis-related expenses.¹⁶ Whether your clinic offers molecular testing, a combined rapid-plus-culture approach, or rapid test alone depends on insurance coverage, available equipment, and local guidelines. In the United States, most pediatric offices still follow the rapid-test-with-culture-backup model, while many adult-focused practices stop at the rapid test.

At-Home Strep Tests

Over-the-counter strep test kits have become available in recent years, using the same rapid antigen technology found in clinics. They come with a swab, extraction chemicals, and a test strip, and you perform the throat swab on yourself or a family member. The accuracy of these kits, when performed correctly, is comparable to a clinic-administered rapid test: they detect strep correctly about 86% of the time and rule it out about 95% of the time. The key phrase is “when performed correctly.” Swabbing the back of your own throat thoroughly enough is genuinely difficult. Many people gag and pull the swab away too quickly, and this can easily lead to a false negative.

At-home tests can be useful as a first pass, especially if you want to decide whether a clinic visit is warranted. A positive result is reliable and means you should seek treatment. A negative result is less definitive. If your symptoms are strongly suggestive of strep, particularly in a child, a negative home test should not be the end of the story. Getting a professional evaluation that might include a more sensitive test or a backup culture is a reasonable next step. These kits do not replace clinical judgment, especially for children, where the stakes of a missed diagnosis are highest.